Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

NCT01028027 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis
Keratitis
Blepharitis

Interventions

DRUG: Loteprednol and tobramycin
DRUG: Tobramycin and dexamethasone

Sponsor

Bausch & Lomb Incorporated